24.6 C
New York
Sunday, June 14, 2026

Tag: radiation

Xinhua Silk Road: 3rd Tianjin International Shipping Industry Expo kicks off to boost win-win cooperation

BEIJING, June 14, 2025 /PRNewswire/ -- The third Tianjin International Shipping Industry Expo (TISIE) kicked off in north China's Tianjin Municipality on Thursday, attracting the...

Unibel : COMMUNIQUE DE PRESSE DU 13 JUIN 2025 RELATIF A LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE DE LA SOCIETE

COMMUNIQUE DE PRESSE DU 13 JUIN 2025
RELATIF A LA MISE EN ŒUVRE DU RETRAIT OBLIGATOIRE DE LA SOCIETE

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease...

As Public Cancer Funding Wavers, Oncology’s Brightest Breakthroughs Are Coming From Industry

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /CNW/ -- Equity Insider News Commentary – The 2025 ASCO...

Topeka’s KMC Dermatology Is First in Kansas to Offer Nonsurgical GentleCure™ Treatment Option for Common Skin Cancer

BURR RIDGE, Ill., June 11, 2025 /PRNewswire/ -- SkinCure Oncology, the industry leader in providing a comprehensive cancer center model for the delivery of...

SATISFACTION WITH CARE EXPERIENCES MAKES A SIGNIFICANT DIFFERENCE FOR CANCER SURVIVORS, AREA ONCOLOGIST SAYS

SOMERSET, N.J., June 11, 2025 /PRNewswire/ -- In honor of National Cancer Survivor Month, ProCure Proton Therapy Center highlights a vital element in the care journey:...

Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand

HONG KONG and SHANGHAI, June 11, 2025 /PRNewswire/ -- The Ping An Good Doctor Brand Revamp & Ping An Healthcare Services Brand Launch Conference was...

Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month

Timed with National Men’s Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men1—and encourages them to take control of their health.

Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer

Target Action (PDUFA) Date set for October 7, 2025 Application based on data from IMforte, the first Phase 3 trial demonstrating statistically significant and clinically...

Canadian Nuclear Laboratories and the University of Ottawa Accelerate Low Dose Radiation Research and Foster Next Generation of Scientists

New partnership furthers Canada’s international leadership in low dose radiation research
New partnership furthers Canada’s international leadership in low dose radiation research

Myosin Therapeutics Receives FDA Clearance to Initiate First-in-Human Trial of MT-125 in Glioblastoma

JUPITER, Fla., June 9, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies targeting molecular motors, today announced that the...

Fuse Welcomes Esteemed Former Nuclear and National Security Officials to Advisory Board

Advisory Board Includes Senior Officials from U.S. Strategic Command, U.S. Navy, U.S. Army, the National Security Agency, and the Department of Justice Seasoned Leaders Come...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRadiation